首页> 外文期刊>Turkish journal of biology >A preliminary proteomic evaluation of smooth muscle cells in thoracic aortic aneurysms
【24h】

A preliminary proteomic evaluation of smooth muscle cells in thoracic aortic aneurysms

机译:胸主动脉瘤平滑肌细胞的蛋白质组学初步评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aortic aneurysm is characterized as localized degeneration of the aorta leading to advanced weakening and widening of the vessel. While the exact mechanisms have yet to be determined, current studies indicate that the degradation of extracellular matrix (ECM) proteins and apoptosis of vascular smooth muscle cells (SMCs) may result in extendibility, dilation, and rupture of the vessel. Within the aortic wall, SMCs are implicated as key components involved in disease development, as numerous molecular changes have been reported to occur. Most current studies involve either investigation of proteins constituting a group or pathway in SMCs, or analyses of the whole aortic tissue. In order to determine which proteins are important in the development of thoracic aortic aneurysms (TAAs), we performed comparative proteomic analyses using cultured SMCs from TAAs versus controls. Label-free nano LC-MS/ MS analysis of cell extracts resulted in the identification of 256 proteins, 26 of which were differentially regulated by ≥1.4-fold. Both previously described and new proteins were identified that were involved in oxidative stress, ECM formation, energy metabolism, or the 14-3-3 pathway. Among these, differential expression of SerpinH1, a protease inhibitor for collagenases, was further verified via immunoblotting. Here we have attempted to shed light on the cellular mechanisms of TAAs.
机译:主动脉瘤的特征是主动脉局部变性导致血管的弱化和增宽。尽管尚未确定确切的机制,但目前的研究表明,细胞外基质(ECM)蛋白的降解和血管平滑肌细胞(SMC)的凋亡可能导致血管的延伸,扩张和破裂。在主动脉壁内,SMC被认为是疾病发展的关键组成部分,因为据报道发生了许多分子变化。当前大多数研究涉及对SMC中组成基团或途径的蛋白质进行研究,或对整个主动脉组织进行分析。为了确定哪些蛋白在胸主动脉瘤(TAA)的发展中很重要,我们使用来自TAA的培养的SMC与对照进行了蛋白质组学比较分析。细胞提取物的无标记纳米LC-MS / MS分析导致鉴定出256种蛋白质,其中26种蛋白质的差异被≥1.4倍调节。既鉴定了先前描述的蛋白质,也鉴定了与氧化应激,ECM形成,能量代谢或14-3-3途径有关的新蛋白质。其中,通过免疫印迹进一步证实了SerpinH1(胶原酶的蛋白酶抑制剂)的差异表达。在这里,我们试图阐明TAA的细胞机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号